106531-51-5

Usage

Uses

Used in Pharmaceutical Industry:
FURO[2,3-C]PYRIDIN-3(2H)-ONE HYDROCHLORIDE is used as a key building block for the synthesis of various biologically active molecules. Its unique structure and reactivity make it a valuable component in the development of new drugs and medical products, contributing to advancements in healthcare and medicine.
Used in Chemical Research and Experimentation:
Due to its distinctive structural features and chemical reactivity, FURO[2,3-C]PYRIDIN-3(2H)-ONE HYDROCHLORIDE is also utilized in chemical research and experimentation. It serves as a subject of study for understanding its properties and potential applications in various chemical processes and reactions, thereby expanding the knowledge base in the field of chemistry.

Upstream product

• 10128-71-9 3-hydroxyisonicotinic acid 
• 18343-02-7 Ethyl 2-(4-Ethoxycarbonyl-3-pyridyloxy) acetate 
• 18342-97-7 ethyl 3-hydroxyisonicotinate 
• 106531-50-4 Ethyl 3-Hydroxyfuro<2,3-c>pyridine-2-carboxylate 

Downstream Products

• 927807-04-3 3-(tert-butyldiphenylsilyloxy)furo[2,3-c]pyridine 
• 927806-76-6 2-p-Tolylfuro[2,3-c]pyridin-3-ol 
• 19539-50-5 furo<2,3-c>pyridine 
• 106531-53-7 2,3-Dihydrofuro<2,3-c>pyridin-3-ol 

Relevant academic research and scientific papers

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

Compounds of Formulas (I), (IIA) and (IIIA) are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formulas (I), (IIA) and (IIIA) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Raf inhibitor compounds and methods of use thereof

Compounds of Formula I are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formula I, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Furopyridines. V. A Simple Synthesis of Furopyridine and Its 2- and 3-Methyl Derivatives

A simple synthesis of furopyridine and its 2- and 3-methyl derivatives from ethyl 3-hydroxyisonicotinate (2) is described.The hydroxy ester 2 was O-alkylated with ethyl bromoacetate or ethyl 2-bromopropionate to give the diester 3a or 3b.Cyclization of compound 3a afforded ethyl 3-hydroxyfuropyridine-2-carboxylate (4) which was hydrolyzed and decarboxylated to give furopyridin-3(2H)-one (5a).Cyclization of 3b gave the 2-methyl derivative 5b.Reduction of 5a and 5b with sodium borohydride yielded the corresponding hydroxy derivative 6a and 6b, respectively, which were dehydrated with phosphoric acid to give furopyridine (7a) and its 2-methyl derivative 7b. 4-Acetylpyridin-3-ol (8) was O-alkylated with ethyl bromoacetate to give ethyl 2-(4-acetyl-3-pyridyloxy)acetate (9).Saponification of compound 9, and the subsequent intramolecular Perkin reaction gave 3-methylfuropyridine (10).Cyclization of 9 with sodium ethoxide gave 3-methylfuropyridine-2-carboxylic acid, which in turn was decarboxylated to give compound 10.